Following the discovery of cis-diamminedichloroplatinum(II) (cisplatin) as the successful antitumor drug, 1) the research of the design and synthesis of novel platinum(II) complexes, having more favorable antitumor activities as compared with cisplatin, has been continued. [2] [3] [4] [5] Palladium(II) complexes have been also investigated for developing the new antitumor agents, [6] [7] [8] [9] [10] [11] [12] because palladium(II) has a similar coordination mode and chemical properties to platinum(II).
0.76 mmol of bpy, phen or bpa were mixed with 0.76 mmol of PdCl 2 · 2NaCl · 3H 2 O in 5 ml of 80% (v/v) methanol-water solution for about 5 min at room temperature. The precipitates appeared after adding palladium salt. Each precipitate was dried under a vacuum and assumed as [Pd(bpy)Cl 2 ], [Pd(phen)Cl 2 ] and [Pd(bpa)Cl 2 ]. Then, 0.015 mmol of the precipitate was reacted with equal moles of Gly and NaHCO 3 in 5 ml of water solution for about 1 h at 333-343 K, until the volume of the reaction mixture was concentrated to ca. 1 ml. The concentrated solution was allowed to stand at room temperature for slow evaporation. Two weeks later, the light yellow needle crystals of the complex 1 and 3 suitable for X-ray diffraction studies were obtained from the mother liquid, and three months later the brown needle crystal of the complex 2 was obtained.
The results of the elemental analyses of the complexes were as follows: X-Ray Crystallography The data was corrected for Lorentz and polarization effects. The structure was solved by direct methods 20) using the Crystal Structure 21) software package. The refinement was performed using SHELXL-97. 22) All H atoms including water molecules were located from difference Fourier maps and placed at idealized positions and treated as riding, with C-H distance of 0.93 and U iso (H) values equal to 1.2 U eq (C) and U iso (water H) values equal to 1.5 U eq (C) (U eq is the equivalent isotropic displacement parameter for the pivot atom). 
DNA-Binding and Cleavage Experiments
The binding experiment of the complexes to CT DNA was studied using the fluorescence method. Competitive binding studies were performed by measuring the emission of ethidium bromide (EB) bound to DNA, which shows enhanced emission intensity due to its intercalative binding to DNA. 23, 24) The competitive binding of the complexes to DNA reduces the emission intensity of EB with either a displacement of the bound EB from the bound to the free state or the bound complex quenching the emission. 25, 26) In a typical binding experiment, a 2 ml solution of 1.45 mM EB was added to a volume of 300 ml of 100 mM CT DNA solution. An aliquot of 3 mM solution of the complexes in distilled water was added to the EB-DNA solution. After the mixtures were incubated overnight for equilibration at 298 K, fluorescence measurements were taken at l ex of 545 nm and l em of 600 nm at 298 K.
The fluorescence intensities at 600 nm were plotted against the complex concentration to yield a slope that showed the relative extent of binding of the complexes to DNA. A control experiment was also done with the EB in the absence of DNA for correcting the fluorescence intensity.
Absorption spectra of the complexes were measured in similar conditions with the fluorescence measurements. At this time, the final concentration of the complex was 10 mM, and those of CT-DNA were 20-150 mM, at which the molar ratios of [DNA]/[Complex]ϭR were changed as 2, 5, 10 and 15. The mixtures of the complex and DNA were equilibrated overnight at 298 K before measurements. The absorption spectra of the mixture were measured at the wavelength region of 220-340 nm at 298 K, and the difference spectra were obtained by subtracting the absorption of DNA from that of the mixture.
CD measurements were made at similar conditions with the absorption and fluorescence measurements in 10 mM Tris-HCl buffer, pH 7.4, containing 50 mM NaCl. The final concentrations of CT DNA and the complex are 150 mM and 50 mM, at which the molar ratio of [DNA]/[Complex]ϭR was 3. The mixtures of the complex and DNA were equilibrated overnight at 298 K before measurements. The CD spectra of the mixture were measured at the wavelength region of 240-320 nm at 298 K.
The cleavage experiments were performed by the gel electrophoresis using SC DNA in 10 mM Tris-HCl buffer, pH 7.4, containing 50 mM NaCl. 13, 15) The reaction mixtures were prepared as follows: both 4 ml of 7 mM H 2 O 2 and 4 ml of 7 mM ascorbic acid were added to a mixture of 20 ml of SC DNA (0.05 mg/ml) and 6 ml of 300 mM complexes, followed by dilution with Tris-HCl buffer to a total volume of 40 ml. The final concentration of the complexes was 45 mM, and that of H 2 O 2 and ascorbic acid was 525 mM. The reactions were performed after incubating the reaction mixture at 298 K for 1 h in the presence and/or absence of the complexes. For the experiments on the concentration dependence of the complexes, 3 ml of H 2 O 2 , 3 ml of H 2 O 2 and 2-10 ml of the complexes were used in the above reaction mixture of total 40 ml. The final concentrations of the complexes were changed from 15 to 75 mM, and that of H 2 O 2 and ascorbic acid was 525 mM.
A loading buffer (3 ml) containing 0.03% bromophenol blue, 0.03% xylene cyanol, and 60% glycerol was added to 20 ml of the reaction mixture and electrophoresis was performed at 50 V for 70 min in Tris-acetate-EDTA (TAE) buffer, pH 8.1, using 1% agarose gel. After electrophresis, the agarose gel was dyed in EB solution (0.5 mg/ml).
The cleavage of SC DNA was monitored by photographing the fluorescence of intercalated EB using Amersham Pharmacia Biotech Image Master VDS-CL illuminator.
The concentration of CT DNA was determined by measuring the absorption intensity at 260 nm with the molar extinction coefficient value of 6600 M Ϫ1 cm Ϫ1 in 10 mM Tris-HCl buffer, pH 7.4, containing 50 mM NaCl.
27)
The concentration of SC DNA was calculated from the contents of the sample vials (0.5 mg/ml).
Results and Discussion
Crystal Structures The structure of the complex 1 is shown in Fig. 1a . The Pd(II) atom has a distorted square-planar four-coordination geometry and is bonded to two heterocyclic N atoms, and an N atom and an O atom from Gly in a equatorial plane. The complex itself is positively charged, and neutralized by free Cl Ϫ anion located nearby. In the square-planar coordination, the rms deviation of Pd1 from 
90.7 (2) the mean plane through O1, N1, N2 and N3 atoms is 0.006(1) Å. The five membered chelate rings, Pd1-N1-C5-C6-N2 and Pd1-O1-C11-C12-N3, are formed with bpy and Gly ligand, respectively. These rings are almost planar with the dihedral angle between the planes Pd1-N1-N2 and Pd1-N3-O1 of 0.76(9)°. Two pyridine rings of bpy ligand are also planar with the dihedral angle of 0.4(3)°. The Gly takes a eclipsed conformation with a little large torsion angle, N3-C11-C12-O1, Ϯ17.1(3)°. This may be caused by the steric hindrance between the H atom of C1 and the H atom of the amino group. The packing pattern of 1 with the hydrogen-bond networks is shown in Fig. 1b .
The complex molecules are connected by the hydrogen bond network through hydrated water molecules and Cl The stacking layer arrays along c axis. The overall complex molecules are stabilized by the H-bond networks together with the p-p interactions.
The structure of the complex 2 is shown in Fig. 2a . The coordination geometry and atoms around the central Pd(II) atom is the same with 1. The rms deviation of Pd1 from the mean square plane (N1/N2/O1/N3) is 0.004(2) Å as similar to 1. The dihedral angle between (N1/Pd1/N2) and (N3/Pd1/O1) planes is 1.416(6)°. The Gly ligand takes an eclipsed conformation with torsion angle, N3-C13-C14-O1, is Ϯ11.8(7)°. The phen ring is planar. 910 Vol. 56, No. 7 The packing pattern of 2 with the hydrogen-bond networks is shown in Fig. 2b .
The complex molecules are connected to each other by the available H-bonds. The p-p interaction is also present between phen rings with the distances between Cg1(N2/ C6/C7/C8/C9/C10) and Cg2(C4/C5/C6/C7/C11/C12) [symmetry code: (1/2Ϫx, 1/2ϩy, ϩz)] of 3.643(4) Å. The overall complex molecules are stabilized by the H-bond network together with the p-p interaction.
The structure of the complex 3 is shown in Fig. 3a . Two independent complex molecules are present in an asymmetric unit. Their coordination geometries resemble each other, and both Pd1 and Pd2 have a distorted square-planar four coordination geometry like the complexes 1 and 2. Ligand atoms are also the same as 1 and 2. Two Cl Ϫ anions locate nearby the complex. Each Pd atom deviates from the mean square planes (N1/N2/O1/N4) and (N5/N6/O3/N8) by 0.036(2) Å and 0.028(2) Å, respectively. The six membered chelate rings, Pd1-N1-C5-N3-C6-N2 and Pd2-N5-C17-N7-C18-N6 are formed with bpa ligands, and five membered rings with Gly ligands. The two pyridine rings of bpa ligand of each complex are slightly twisted with the dihedral angle 20.5(2)°and 20.3(2)°for Pd1 and Pd2 complex, respectively. This may be caused by the short contact between the H atom of C1 and the H atom of the amino group as in the case of 1 and 2. The Gly ligand takes an eclipsed conformation with the torsion angle N4-C11-C12-O1, Ϯ8.7(7)°a nd N8-C23-C24-O3, Ϯ11.9(7)°.
The packing pattern of the complex 3 with the hydrogenbond network is shown in Fig. 3b , where the H atoms attached to the hydrated water O5, O6 and O7 atoms disordered. Available H-bond networks are formed through water molecules, Cl Ϫ atoms and the NH group of bpa. The face to face p-p interactions are present between bpa ligands with distances of 3.630(6) Å for the stacking between Cg1(N1/C1/C2/C3/C4/C5) and Cg2(N5/C13/C14/C15/C16/ C17) [symmetry code: (ϩx, ϩy, ϩz)], and 3.838(6) Å for Cg3(N2/C6/C7/C8/C9/C10) and Cg4(N6/C18/C19/C20/C21/ C22). The overall complex molecules are stabilized by the Hbond network together with the p-p interaction.
In all of the complex molecules, the Pd(II) atom has a distorted square-planar four-coordination geometry and is bonded to two heterocyclic N atoms, and an N atom and an O atom from Gly in a equatorial plane. The heterocyclic ligands behave as N,NЈ bidentate ligands, and Gly ligand behaves as a N,O bidentate ligand. All of the complexes are positively charged, and neutralized by the free Cl Ϫ anion located nearby. The positively charged complexes may have an advantage to interact with the negatively charged phosphate groups of DNA molecule. The typical coordination bond distances and angles are summarized in Table 2 .
DNA Binding and Cleavage Studies The relative fluorescence intensity of EB was reduced by addition of the complexes into the EB-DNA solution. The extent of the fluorescence reduction of EB reflects the extent of binding of the complexes to DNA mainly by intercalation. 28, 29) The binding property of the complexes to DNA is reflected by the slope of the quenching plot (Fig. 4) . The extent of the binding of the complex 2 is predominant within three complexes. The values of the apparent binding constant (K app ) 30, 31) were deduced from the slope of the quenching plot according to the equation K app,complex [Complex] suggest that the three complexes compete with the intercalative EB binding to DNA in a different degree. Especially, 2 has a strong DNA binding ability as compared with the others.
The absorption spectra of the complexes in the presence of CT DNA are shown in Figs. 5a, b and c. Apparently large hypochromic effect of 2 was observed (Fig. 5b) . On the other hand, the hypochromic effect of 1 (Fig. 5a) and 3 (Fig. 5c ) was small and resemble each other.
Mital and Srivastava 32) studied the interaction of the ternary Pt(II) complex with phen and glycine, [Pt(Gly)(phen)] ϩ with CT DNA using fluorescence method in the similar experimental conditions within this study, and suggested that the complex intercalates into CT DNA at low concentrations of the metal complex to nucleotide concentration, with external binding at higher complex concentrations after initial intercalation. The other several Pt(II) complexes with phen have been known to bind to DNA as intercalators.
33) The existence of the p-p interaction between phen planes in the crystal packing of 2 (Fig. 2b) suggests the formation of the intercalative binding. Further, in crystal structures of all complexes, the Cl Ϫ anion is not coordinated to [Pd(Gly)(X)] ϩ . Therefore, positively charged complexes can easily interact with the negatively charged phosphate groups on DNA molecule. Circular dichroism spectra shown in Fig. 6 were obtained using similar conditions as fluorescence and absorption measurements. The CD spectrum of CT DNA consists of a positive band at 275 nm a negative band at 245 nm, characteristic of DNA in right handed B form. 34) When 2 is incubated with CT DNA at Rϭ3 which is enough to produce the absorption change (Fig. 5b) , the CD spectrum of DNA undergoes the small red shift in the positive band at 275 nm and the reduction in the negative band at 245 nm. This spectral change is similar to that observed for DNA binding study 35) of Pt(II) complex of phen, [Pt(phen)(en)]Cl 2 (where en is ethylenediamine) at Rϭ1.1 in the similar conditions with this study, in which the Pt(II) complex with phen is considered as the most efficient intercalator. The CD change also resembles that observed for DNA binding of Ni(II) complex of phen, [Ni(phen)(edda)] (where edda is N,NЈ-ethylenediaminediacetic acid) 36) at Rϭ1, and that for the binding of altromycin B.
37) These compounds have been also considered as intercalators. The intercalation of the above compounds may be favored when the double helix adopts the A-conformation as reflected by the reduction at 245 nm. 37) On the other hand, complexes 1 and 3 did not show little changes of CD bands.
The results of fluorescence, UV, CD and structural studies suggest that the complexes 1, 2 and 3 bind to DNA, and, es- The concentration of CT DNA was 93.2 mM. The excitation and emission wavelengths of EthBr were 545 nm and 600 nm respectively. F 0 and F represent the fluorescence intensity at 600 nm in the absence and presence of the complexes, respectively. pecially, 2 binds to DNA fundamentally by the intercalative binding mode. While the complexes 1 and 3 may bind to the groove of DNA. More precise DNA-binding modes of each complex will be proved by further studies.
The DNA cleavage ability of the complexes has also been investigated by gel electrophoresis using SC DNA. The electrophoretic migration patterns for the cleavage of SC DNA are usually characterized by three forms (Form I, II, III). 28, 29, 33, 38) The fastest migration of the electrophoretic pattern is called Form I, which reflects super coiled DNA. A slower migration pattern is Form II, which reflects nicked circular DNA. Form III reflects linear open circular DNA, which migrates between Form I and Form II. Figure 7 shows the electrophoretic migration patterns of SC DNA in the presence and absence of the complexes, H 2 O 2 and ascorbic acid. A little production of Form II was observed in the presence of H 2 O 2 and ascorbic acid without complexes (lane 3). Control experiments using complex alone did not produce Form II even at a high concentration of 45 mM (lane 4). On the other hand, the apparent increase of Form II was observed by increasing concentrations of 2 in the presence of H 2 O 2 and ascorbic acid (Fig. 7b, lanes 5-9) . In the case of the complexes 1 and 3 (Figs. 7a and c, lanes 5-9) , the conversion of Form I to Form II was also observed like 2, but the concentration dependence of the migration pattern of 2 was clearer as compared with 1 and 3. These electrophoretic results suggest that all of the complexes enhance the oxidative cleavage of SC DNA in the presence of H 2 O 2 and ascorbic acid, although a little cleavage occures even in the presence of H 2 O 2 and ascorbic acid without the complexes. Up to the present, the antibiotic activity of Pd(II) complexes with heterocyclic ligands has been reported in vivo and explained by the intercalation and/or groove binding models, 15, 32, 33, 37, 39) although the precise mechanism is not yet clear. Recently, the cleavage of Form I to Form II of the pUC19 plasmid DNA by the intercalative Pd(II) complex, [Pd 2 (m-bzta) 4 ] · 1.5DMSO (where bztaϭbenzothiazole-2-thiolate) 12) has been reported in vitro. Although the intercalative and/or groove binding of the Pd(II) complexes to DNA followed by the topological change of DNA may be an essential reason for the antibiotic activity of the complexes in vivo, the oxidative cleavage of SC DNA enhanced by the Pd(II) complexes in the presence H 2 O 2 and ascorbic acid may be also worthy for considering the mechanisms of antibiotic activity of the Pd(II) complexes. More precise mechanistic aspects for the antibiotic activity of the Pd(II) complexes should be explored in further physicochemical studies.
Conclusion
The coordination modes of three ternary Pd(II) complexes with the different ligand atoms, N,O bidentate glycine ligand, and N,NЈ bidentate heterocyclic ligand have been structurally characterized. The interaction between Pd(II) atom and ligand atoms are discussed including the packing effects.
DNA binding and cleavage ability of the complexes was also studied. Each of the complexes showed binding propensity to CT DNA, and enhanced cleavage activity for SC DNA in the presence of H 2 
